Cargando…
Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial
BACKGROUND: The evidence for systemic treatments for severe childhood eczema is limited and largely based on extrapolation of data from adult studies. Current therapies are often immunosuppressant and may be associated with both short- and long-term side effects. There is increasing in vitro and mur...
Autores principales: | Chan, Susan, Cornelius, Victoria, Chen, Tao, Radulovic, Suzana, Wan, Mandy, Jahan, Rahi, Lack, Gideon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361704/ https://www.ncbi.nlm.nih.gov/pubmed/28330497 http://dx.doi.org/10.1186/s13063-017-1809-7 |
Ejemplares similares
-
The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan
por: Chen, Tao, et al.
Publicado: (2017) -
Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010) -
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018) -
Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
por: Bracken, Sonali J., et al.
Publicado: (2018) -
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016)